Correlation Between Pliant Therapeutics and Structure Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pliant Therapeutics and Structure Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pliant Therapeutics and Structure Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pliant Therapeutics and Structure Therapeutics American, you can compare the effects of market volatilities on Pliant Therapeutics and Structure Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pliant Therapeutics with a short position of Structure Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pliant Therapeutics and Structure Therapeutics.
Diversification Opportunities for Pliant Therapeutics and Structure Therapeutics
0.89 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Pliant and Structure is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding Pliant Therapeutics and Structure Therapeutics America in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Structure Therapeutics and Pliant Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pliant Therapeutics are associated (or correlated) with Structure Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Structure Therapeutics has no effect on the direction of Pliant Therapeutics i.e., Pliant Therapeutics and Structure Therapeutics go up and down completely randomly.
Pair Corralation between Pliant Therapeutics and Structure Therapeutics
Given the investment horizon of 90 days Pliant Therapeutics is expected to under-perform the Structure Therapeutics. In addition to that, Pliant Therapeutics is 2.8 times more volatile than Structure Therapeutics American. It trades about -0.17 of its total potential returns per unit of risk. Structure Therapeutics American is currently generating about -0.08 per unit of volatility. If you would invest 2,663 in Structure Therapeutics American on December 30, 2024 and sell it today you would lose (686.00) from holding Structure Therapeutics American or give up 25.76% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Pliant Therapeutics vs. Structure Therapeutics America
Performance |
Timeline |
Pliant Therapeutics |
Structure Therapeutics |
Pliant Therapeutics and Structure Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pliant Therapeutics and Structure Therapeutics
The main advantage of trading using opposite Pliant Therapeutics and Structure Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pliant Therapeutics position performs unexpectedly, Structure Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Structure Therapeutics will offset losses from the drop in Structure Therapeutics' long position.Pliant Therapeutics vs. Relay Therapeutics | Pliant Therapeutics vs. Stoke Therapeutics | Pliant Therapeutics vs. Black Diamond Therapeutics | Pliant Therapeutics vs. Arvinas |
Structure Therapeutics vs. Day One Biopharmaceuticals | Structure Therapeutics vs. X4 Pharmaceuticals | Structure Therapeutics vs. Inozyme Pharma | Structure Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
CEOs Directory Screen CEOs from public companies around the world | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Money Managers Screen money managers from public funds and ETFs managed around the world |